摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-二氟-2-甲氧基苯胺 | 114076-35-6

中文名称
3,4-二氟-2-甲氧基苯胺
中文别名
6-氨基-2,3-二氟苯甲醚
英文名称
3,4-difluoro-2-methoxyaniline
英文别名
——
3,4-二氟-2-甲氧基苯胺化学式
CAS
114076-35-6
化学式
C7H7F2NO
mdl
——
分子量
159.135
InChiKey
OHHHWQYSRANYIX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi

SDS

SDS:010c4796996536a4f4ca5680e1f79ea6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3,4-Difluoro-2-methoxyaniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3,4-Difluoro-2-methoxyaniline
CAS number: 114076-35-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7F2NO
Molecular weight: 159.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-二氟-2-甲氧基苯胺三氯氧磷 作用下, 以 二苯醚 为溶剂, 反应 3.0h, 生成 4-chloro-6,7-difluoro-8-methoxyquinoline-3-carbonitrile
    参考文献:
    名称:
    Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound
    摘要:
    Herein, we report the discovery of the first selective and CNS penetrant mGlu(7) PAM (VU6027459) derived from a "molecular switch" within a selective mGlu(7) NAM chemotype. VU6027459 displayed CNS penetration in both mice (K-p = 2.74) and rats (K-p = 4.78), it was orally bioavailable in rats (%F = 69.5), and undesired activity at DAT was ablated.
    DOI:
    10.1021/acsmedchemlett.0c00432
  • 作为产物:
    描述:
    2,3-二氟-6-硝基苯甲醚 在 ammonium chloride 、 铁粉 作用下, 以 甲醇 为溶剂, 生成 3,4-二氟-2-甲氧基苯胺
    参考文献:
    名称:
    Quinoline-3-carboxylic acid derivatives
    摘要:
    公式(I)的化合物:##STR1##(其中R.sup.1是烷氧基,R是烷基,卤代烷基,烷基氨基,环烷基或可选择取代的苯基,X是氯或氟,Y选择自特定的杂环)具有出色的抗菌活性。可以通过将Y代表的基团引入对应的化合物中来制备它们,其中Y被卤原子取代。
    公开号:
    US04997943A1
点击查看最新优质反应信息

文献信息

  • [EN] BENZOTHIADIAZINE COMPOUNDS<br/>[FR] COMPOSÉS BENZOTHIADIAZINE
    申请人:GLAXOSMITHKLINE IP DEV LTD
    公开号:WO2017098421A1
    公开(公告)日:2017-06-15
    The invention is directed to substituted benzothiadiazine derivatives. Specifically, the invention is directed to compounds according to Formula (I):wherein R, R1, R2, R3, R4 and R5 are as defined herein. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, autoimmune diseases, infections, atherosclerosis, and ischemia-reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    本发明涉及取代苯并噻二嗪衍生物。具体而言,本发明涉及式(I)化合物:其中R、R1、R2、R3、R4和R5定义如下。本发明的化合物是CD73的抑制剂,可用于治疗癌症、前癌综合症和与CD73抑制相关的疾病,如艾滋病、自身免疫病、感染、动脉粥样硬化和缺血-再灌注损伤。因此,本发明进一步涉及包含本发明化合物的药物组合物。本发明更进一步的涉及使用本发明化合物或包含本发明化合物的药物组合物抑制CD73活性和治疗相关疾病的方法。
  • [EN] TYK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE TYK2 ET LEURS UTILISATIONS
    申请人:NIMBUS LAKSHMI INC
    公开号:WO2018071794A1
    公开(公告)日:2018-04-19
    The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
    本发明提供了化合物、其组合物以及使用它们来抑制TYK2并治疗TYK2介导的疾病的方法。
  • [EN] ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFNALPHA RESPONSES<br/>[FR] COMPOSÉS PYRIDYLE SUBSTITUÉS PAR ALKYL-AMIDE, UTILES COMME MODULATEURS D'IL-12, IL-23 ET/OU DE RÉPONSES À L'IFNΑ
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015069310A1
    公开(公告)日:2015-05-14
    Compounds having the following formula (I): or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R1, R2, R3, R4, and R5 are as defined herein, are useful in the modulation of IL-12, IL-23 and/or IFNα by acting on Tyk-2 to cause signal transduction inhibition.
    具有以下化学式(I)的化合物,或其立体异构体或药用可接受的盐,其中R1、R2、R3、R4和R5如本文所定义,在通过作用于Tyk-2引起信号传导抑制的过程中,对IL-12、IL-23和/或IFNα的调节是有用的。
  • [EN] 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
    申请人:BAYER AG
    公开号:WO2020216774A1
    公开(公告)日:2020-10-29
    Compounds of formula (I) for use in the treatment or prophylaxis of a disease, which is a hyperproliferative disease and/or a disorder responsive to induction of cell death, selected from a haematological tumour, a solid tumour and/or metastases thereof, said tumour harbouring a mutant EGFR with exon 19 or 21 mutations, and their use as pharmaceuticals.
    式(I)的化合物用于治疗或预防一种高增殖性疾病和/或对诱导细胞死亡敏感的疾病,所述疾病选自血液肿瘤、实体肿瘤和/或其转移瘤,所述肿瘤携带具有外显子19或21突变的突变EGFR,并将其用作药物。
  • Practical Synthesis of<i>N</i>-Cyclopropylanilines via Direct Condensation of Anilines with [(1-Ethoxycyclopropyl)oxy]trimethylsilane
    作者:Yasuo Yoshida、Kazuto Umezu、Yusuke Hamada、Naoya Atsumi、Fumiya Tabuchi
    DOI:10.1055/s-2003-42072
    日期:——
    N-Cyclopropylanilines were obtained in high yield through the condensation reaction of anilines with [(1-ethoxycyclopropyl)oxy]trimethylsilane by a simple two-steps operating process, without purification of the intermediate, 1-alkoxy-1-anilinocyclopropane.
    N-环丙基苯胺通过苯胺与[(1-乙氧基环丙基)氧]三甲基硅烷的缩合反应,以高产率获得,采用简单的两步操作过程,无需对中间体1-烷氧基-1-苯胺环丙烷进行纯化。
查看更多